About the Book
VIBERZI Drug Profile, 2023This report focuses on VIBERZI and covers the following critical aspects of this drug:
- United States patents
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
ContentsUS PatentsUS District Court LitigationInternational (exUS) PatentsSupplementary Protection CertificatesClinical TrialsDrug Prices - Average Pharmacy CostDrug Prices - Best Wholesale PriceFinished Product SuppliersBulk API SourcesCompanies Mentioned: ABBVIE, ALLERGAN, INC., MEDCHEMEXPRESS MCE, SUN-SHINE CHEMICAL, ABACHEMSCENE, ZINC, ACORN PHARMATECH PRODUCT LIST, AKOS CONSULTING & SOLUTIONS, DC CHEMICALS, LABNETWORK, A WUXI APPTEC COMPANY, ABCR GMBH, FINETECH INDUSTRY LIMITED, ABMOLE BIOSCIENCE, CHEMIELIVA PHARMACEUTICAL CO., LTD, CANGZHOU ENKE PHARMA TECH CO., LTD., MUSECHEM, KEY ORGANICS/BIONET, HANGZHOU APICHEM TECHNOLOGY, YUHAO CHEMICAL, AA BLOCKS, ADOOQ BIOSCIENCE, LAN PHARMATECH, MOLPORT, THE BIOTEK, SMOLECULE, APEXMOL, BENCHCHEM, CYMITQUIMICA, STARSHINE CHEMICAL, CHEMENU INC., 001CHEMICAL, RR SCIENTIFICCountries Mentioned: United States, Argentina, Austria, Australia, Brazil, Canada, China, Colombia, Costa Rica, Cyprus, Denmark, Ecuador, Spain, Hong Kong, Croatia, Hungary, Israel, Japan, South Korea, Lithuania, Luxembourg, Montenegro, Mexico, Malaysia, Nicaragua, Netherlands, Norway, New Zealand, Philippines, Poland, Portugal, Serbia, Singapore, Slovenia, Turkey, Taiwan, Ukraine, South Africa